Article Details

ODESSA-UC Study Compares Dose Escalation in Vedolizumab, AntiTNF-α for Ulcerative Colitis

Retrieved on: 2023-12-02 14:04:01

Tags for this article:

Click the tags to see associated articles and topics

ODESSA-UC Study Compares Dose Escalation in Vedolizumab, AntiTNF-α for Ulcerative Colitis. View article details on HISWAI: https://www.hcplive.com/view/odessa-uc-study-compares-dose-escalation-in-vedolizumab-antitnf--for-ulcerative-colitis

Excerpt

The cross-sectional analysis of data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2008 revealed a higher intake ...

Article found on: www.hcplive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up